News and Announcements
Your Exclusive Opportunity to Invest in Wholesale Investor | Australasia’s Leading Private Investment Platform | Developing AI-Driven Capital Raising and Digital Investment Banking Tools for Emerging
- Published May 18, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
“As a subscriber to Wholesale Investor, I invite you to participate in our Series B capital raising, to assist us in funding the acceleration of our CRIISP (Capital Raising Intelligent Investment Secondary Platform) development and business growth strategy. CRIISP development will focus on AI-Driven Capital Raising and Digital Investment Banking Tools for emerging companies.”
Steve Torso, Founder, Wholesale Investor
Wholesale Investor – Raising $5mill – Investment highlights
- Established and rare 3-sided marketplace (across multiple countries) with over 11 years of proven track record.
- Established upsell/cross-sell products and new products being created
- Clients have ranged from International and Local Governments, Stock Exchanges, Venture Capital Funds, ASX Listed Companies, Pre-IPO, and Innovative Private companies. Sector agnostic.
- Shareholders include Investec, BMYG, and Uni Innovate. Other private investors’ backgrounds range from Private Equity, Investment Banking, Funds Management, Corporate Finance, Wealth Management, and Venture Capital, spanning across 5 countries.
- CRIISP Traction includes over 600+ Dealrooms and 3500+ users. Soon to be integrated with the WI investor ecosystem of 29,300
- Experienced Board and Management. Between them, they have Listed companies on the ASX, Founded a Neo Bank, and Invested in over 50+ technology companies. Significant experience in capital raising, acquisitions, and exits.
- Proven end to end virtual and digital solution for the promotion and facilitation of capital raising and investment
- Over 25% of revenue generated from international clients.
Wholesale Investor – Overview
About Wholesale Investor
WHOLESALE INVESTOR IS Australasia’s leading private investment platform for emerging companies. Wholesale Investor has now grown to an ecosystem of 29,300+ HNW, Professional, and International Investors across Australia, ASEAN, and the UK.
Problem: Inefficient private markets are a multi-billion opportunity to solve
The capital-raising process has inefficiencies and is frustrating for everyone involved. Money and time are consistently wasted, investor attraction and discovery is frustrating. You have a fragmented ecosystem, manual processes, legacy systems, isolated solutions, lack of investor connectivity and minimal to no analytics. Current online platforms charging 6-8% success fees compete with the ecosystem, not enabling it.
Solution: AI-Driven Capital Raising, Digital Investment Banking Tools and Subscription Based Deal Making
After working with 1000’s companies and 10’s of thousands of investors, has lead us to the development of CRIISP. Capital Raising Intelligent Investment Secondary Platform. A platform that saves time, saves money, and improves the speed to an outcome for all parties.
Software-driven, ecosystem enabled, end to end solution, access to investors, AI-Driven Matchmaking, and detailed analytics. The platform will feature Digital Investment Banking tools for growth companies. These include; Bookbuilds, Deal Syndications, Secondary Sales, SME Debt, and Whitelabel integrations.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
